Sort
40,608 grants matching “prostate cancer”
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation
$342,988Luksana Chaiswing · University Of Kentucky · R01 · FY2022 · CA
Targeting Mitochondrial Redox Capacity to Overcome Cancer Subtype that Regrowth After Radiation
$342,988Luksana Chaiswing · University Of Kentucky · R01 · FY2023 · CA
Identification of natural products to treat neoplastic disease
$342,963Benjamin Nicholson · Progenra, Inc. · R43 · FY2012 · CA
INBRE OUTREACH CORE
$342,958Joan Barber · University Of Delaware · P20 · FY2007 · RR
Androgen Receptor Targeted Vaccines for Prostate Cancer
$342,928Douglas G McNeel · University Of Wisconsin-Madison · R01 · FY2014 · CA
Novel Full-length Cdnas Differentially Expressed During Hematopoietic Commitment
$342,927Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2009 · HL
Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer
$342,927Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · R37 · FY2024 · CA
Refining castration use for recurrent prostate cancer
$342,918Ted Albert Skolarus · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Elucidating the Role of Trop2 in Prostate Cancer
$342,914Tanya I Stoyanova · University Of California Los Angeles · R37 · FY2024 · CA
Radiation-induced astrocyte dysfunction and cognitive decline
$342,913Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · NS
Radiation-induced astrocyte dysfunction and cognitive decline
$342,913Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · NS
Radiation-induced astrocyte dysfunction and cognitive decline
$342,913Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · NS
Radiation-induced astrocyte dysfunction and cognitive decline
$342,913Zoltan Istvan Ungvari · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · NS
Organic Sythesis
$342,882Ouathek Ouerfelli · Sloan-Kettering Inst Can Research · P30 · FY2017 · CA
Low Level Traces Mapping using Monochromatic X-Rays
$342,837X-Ray Optical Systems, Inc. · R44 · FY2003 · RR
Impact of Fn14-targeted Nanoparticles for Triple-Negative Breast Cancer
$342,815Anthony J. Kim · University Of Maryland Baltimore · R37 · FY2019 · CA
Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer
$342,815Toni M. Antalis · University Of Maryland Baltimore · R01 · FY2019 · CA
Role of histone demethylase JMJD1A in the DNA damage response of prostate cancer cells
$342,815Jianfei Qi · University Of Maryland Baltimore · R01 · FY2019 · CA
Therapeutic Targeting of Wnt Signaling
$342,807Dianqing Wu · Yale University · R01 · FY2008 · CA
Quantitative Mass Spectrometry
$342,783Kenneth Tomer · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression
$342,730Jay H Fowke · Vanderbilt University · R01 · FY2011 · DK
High-throughput Assay Development for Screening Inhibitors of SUMO Ligases
$342,725Jiayu Liao · University Of California Riverside · R01 · FY2011 · AI
Phosphorylation-dependent regulation of GLI transcription factors
$342,713Scott Atwood · University Of California-Irvine · R01 · FY2021 · CA
Viral vector technology for cell type specific gene delivery
$342,667Daniel Schmidt · University Of Minnesota · R01 · FY2023 · GM
Viral vector technology for cell type specific gene delivery
$342,667Daniel Schmidt · University Of Minnesota · R01 · FY2022 · GM